Raynaud's phenomenon epidemiology and demographics

Revision as of 18:55, 8 November 2012 by Shankar Kumar (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Raynaud's phenomenon Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Raynaud's phenomenon from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Raynaud's phenomenon epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Raynaud's phenomenon epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Raynaud's phenomenon epidemiology and demographics

CDC onRaynaud's phenomenon epidemiology and demographics

Raynaud's phenomenon epidemiology and demographics in the news

Blogs on Raynaud's phenomenon epidemiology and demographics

Directions to Hospitals Treating Raynaud's phenomenon

Risk calculators and risk factors for Raynaud's phenomenon epidemiology and demographics

Editors-In-Chief: Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Age

There is a familial component to primary Raynaud's, and presentation is typically before 30.

Gender

The phenomenon is more common in women than men, with the Framingham Study finding that 5.8% of men and 9.6% of women suffered from it.

References


Template:WikiDoc Sources